← Open Payments lookup

MARCELLA POMERANZ: Open Payments

NPI 1174064083 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,641 in 104 payments from 15 companies in 2025. Trend: 2023 $2,120 · 2024 $1,550 · 2025 $7,641

Speaker / faculty: $5,475Food & beverage: $2,082Education: $84
CompanyPaymentsAmount
Janssen Biotech, Inc.28$3,520
Ardelyx, Inc.8$2,739
Lucid Diagnostics Inc.1$241
ABBVIE INC.11$195
PFIZER INC.12$174
Aimmune Therapeutics, Inc.8$162
Salix Pharmaceuticals, a division of Bausch Health US, LLC8$152
GENZYME CORPORATION14$140
Celltrion USA Inc.5$96
Regeneron Healthcare Solutions, Inc.2$47

Products named: TREMFYA, IBSRELA, STELARA, DUPIXENT, XIFAXAN, SKYRIZI, VELSIPITY, VEGZELMA.

Industry payments across NV — which companies pay providers there.